Skip to main content

Table 2 DAVID analysis of changes in proteins associated with platelet-specific secretion

From: Correction to: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer’s disease

Mean log2

(AD/CT)

R1 vs R2

CV, SD%

Symbol

Protein Name

Ontology Groups

−1.70

0.6%

FGA

fibrinogen alpha chain

A, B, C, E, F

−2.03

7.5%

FGB

fibrinogen beta chain

A, B, C, E, F

−1.69

1.5%

FGG

fibrinogen gamma chain

A, B, C, E, F

−2.02

1.9%

VWF

von Willebrand factor

A, B, C, E

−1.23

39%

PROS1

protein S (alpha)

B, C, E, F

−1.19

59%

FN1

fibronectin 1

B, C, D, F

−1.19

41%

SERPINA1

serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1

B, C, E

−1.47

31%

SPARC

secreted protein, acidic, cysteine-rich (osteonectin)

B, C, F

−2.05

0.9%

THBS1

thrombospondin 1

B, C, F

1.47

1.2%

GP9

glycoprotein IX (platelet)

B, C

−2.82

2.9%

C4BPA

complement component 4 binding protein, alpha

D, E

−1.24

94%

SERPINE1

serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1

E, F

−1.83

66%

TF

transferrin

C

−1.65

10%

HP

haptoglobin-related protein; haptoglobin

D

−1.33

31%

SUSD1

sushi domain containing 1

D